We spoke to developer of the HEK293 cell line, Frank Graham, about the challenges faced and serendipity required to pioneer a ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results